Inventor · disambiguated record
Ananth Annapragada
Also filed as: ANNAPRAGADA ANANTH · ANNAPRAGADA ANANTH V
23 granted patents·13 pending applications·58 citations·filing 1988–2025
93Inventor score
Files withTexas Childrens Hospital13ANNAPRAGADA ANANTH8ALZECA BIOSCIENCES LLC4MARVAL BIOSCIENCES INC2BAYLOR COLLEGE MEDICINE1
Top patents by PatentIndex Score
36 records- 0192US7785568B2Compositions and methods for enhancing contrast in imagingMARVAL BIOSCIENCES INC·Filed 2006·Granted Aug 31, 2010·18 cites·4 claims
- 0289US8357351B2Nano-scale contrast agents and methods of useANNAPRAGADA ANANTH·Filed 2009·Granted Jan 22, 2013·7 cites·23 claims
- 0386US8911708B2Nano-scale contrast agents and methods of useANNAPRAGADA ANANTH·Filed 2012·Granted Dec 16, 2014·5 cites·18 claims
- 0483US9744251B2MRI imaging of amyloid plaque using liposomesTEXAS CHILDREN'S HOSPITAL·Filed 2015·Granted Aug 29, 2017·2 cites·15 claims
- 0582US7713517B2Compositions and methods for enhancing contrast in imagingMARVAL BIOSCIENCES INC·Filed 2004·Granted May 11, 2010·13 cites·19 claims
- 0677US8679531B2Vesicle compositionsANNAPRAGADA ANANTH·Filed 2012·Granted Mar 25, 2014·5 cites·17 claims
- 0774US12298318B2Targeting ligands for tau pathologyTexas Childrens Hospital·Filed 2023·Granted May 13, 2025·0 cites·15 claims
- 0871US2020069820A1Mri imaging of amyloid plaque using liposomesTexas Childrens Hospital·Filed 2019·Application pending·0 cites
- 0968US11141495B2MRI imaging of amyloid plaque using liposomesTexas Childrens Hospital·Filed 2020·Granted Oct 12, 2021·0 cites·20 claims
- 1068US2025281652A1Targeted contrast agents for mri of amyloid depositionTexas Childrens Hospital·Filed 2025·Application pending·0 cites
- 1165US8642013B2Nano-scale contrast agents and methods of useANNAPRAGADA ANANTH·Filed 2008·Granted Feb 4, 2014·5 cites·21 claims
- 1264US11116854B2Targeted contrast agents for MRI of amyloid depositionTexas Childrens Hospital·Filed 2021·Granted Sep 14, 2021·0 cites·18 claims
- 1364US10537649B2MRI imaging of amyloid plaque using liposomesTexas Childrens Hospital·Filed 2016·Granted Jan 21, 2020·0 cites·18 claims
- 1464US2023398238A1Targeted contrast agents for mri of alpha-synuclein depositionTexas Childrens Hospital·Filed 2023·Application pending·0 cites
- 1563US11779664B2Targeted contrast agents for MRI of alpha-synuclein depositionTexas Childrens Hospital·Filed 2022·Granted Oct 10, 2023·0 cites·11 claims
- 1662US2022023445A1Targeted contrast agents for mri of amyloid depositionTexas Childrens Hospital·Filed 2021·Application pending·0 cites
- 1759US11614451B2Targeting ligands for tau pathologyALZECA BIOSCIENCES LLC·Filed 2022·Granted Mar 28, 2023·0 cites·26 claims
- 1859US2024165273A1Self-assembling molecules enabling high performance in vivo imaging in the second near infrared (nir-ii) windowBAYLOR COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 1958USRE45195ECompositions and methods for enhancing contrast in imagingMARVAL PHARMA INC·Filed 2013·Granted Oct 14, 2014·0 cites·29 claims
- 2055US2009311191A1Imaging of atherosclerotic plaques using liposomal imaging agentsANNAPRAGADA ANANTH·Filed 2009·Application pending·0 cites
- 2155US2008131369A1Compositions And Methods For Enhancing Contrast In ImagingMARVEL THERAPEUTICS·Filed 2005·Application pending·0 cites
- 2252US2023136718A1Functionalized liposomes for imaging misfolded proteinsALZECA BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 2349US11241510B2Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR signaturesTexas Childrens Hospital·Filed 2017·Granted Feb 8, 2022·0 cites·10 claims
- 2447US10124078B2Lipid-based nanoparticlesBOARD OF REGENTS OF THE UNIV OF HOUSTON SYSTEM·Filed 2017·Granted Nov 13, 2018·0 cites·20 claims
- 2547US2021170055A1Targeted contrast agents for mri of amyloid depositionTexas Childrens Hospital·Filed 2021·Application pending·0 cites
- 2646US11052162B2Liposomal gadolinium (GD) contrast agent “NMRX” for T1-MRITexas Childrens Hospital·Filed 2017·Granted Jul 6, 2021·0 cites·19 claims
- 2746US9801957B2Lipid-based nanoparticlesANNAPRAGADA ANANTH·Filed 2012·Granted Oct 31, 2017·0 cites·12 claims
- 2845US10130326B2Methods and compositions for objectively characterizing medical imagesANNAPRAGADA ANANTH·Filed 2013·Granted Nov 20, 2018·0 cites·20 claims
- 2945US2021252170A1Targeted contrast agents for mri of alpha-synuclein depositionTexas Childrens Hospital·Filed 2021·Application pending·0 cites
- 3043US9278068B2Vesicle compositionsSENSULIN LLC·Filed 2014·Granted Mar 8, 2016·0 cites·23 claims
- 3140US11312685B2Targeting nanoparticlesTEXAS CHILDRENS HOSPTIAL·Filed 2018·Granted Apr 26, 2022·0 cites·56 claims
- 3240US2020261605A1Functionalized liposomes for imaging misfolded proteinsALZECA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 3336US2012003159A1Compositions and methods for enhancing contrast in imagingANNAPRAGADA ANANTH·Filed 2010·Application pending·0 cites
- 3435US12097269B2Dual mode gadolinium nanoparticle contrast agentsKUNDRA VIKAS·Filed 2011·Granted Sep 24, 2024·0 cites·33 claims
- 3535US2021128755A1Targeting ligands for tau pathologyALZECA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 3632US4952547ACatalyst for converting methane to higher hydrocarbons, including aromatic compoundsUNIV MICHIGAN·Filed 1988·Granted Aug 28, 1990·3 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Ananth Annapragada files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →